Hunterian Medicine
Anand Somayaji, CFA is Chief Financial Officer at Hunterian Medicine. In this role, Anand plays a key role in corporate strategy while overseeing the company’s finances, and investor relations.
Anand brings over 19 years of experience spanning investment management and investment banking. Previously, Anand managed AVR Asset Management’s New York office where he led the company’s biotech and event-driven investments for over 10 years. Earlier in his career, Anand worked in Stifel’s equity research group. His career started at M&T Bank’s Management Development program where he worked in Bank’s investor relations, and commercial and investment banking groups. Anand is a Chartered Financial Analyst and graduated from Case Western Reserve University with degrees in Economics and Psychology.
This person is not in any teams
This person is not in any offices
Hunterian Medicine
Hunterian Medicine is a gene-editing company working to cure genetic diseases by correcting DNA mutations using its innovative CRISPR delivery technology.